Filing Flows › Pure Bioscience (PURE) › R&D spending
Pure Bioscience (PURE) R&D spending by quarter
Pure Bioscience's R&D spending was $93K in Q4 FY26 (fourth quarter fiscal 2026), +18% from Q3 FY26. Over the last 7 quarters it ranged from $73K (Q4 FY25) to $93K (Q4 FY26).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q4 FY26 | $93K | +18% | +27% |
| Q3 FY26 | $79K | +7% | -13% |
| Q2 FY26 | $74K | -14% | -9% |
| Q1 FY26 | $86K | +18% | — |
| Q4 FY25 | $73K | -20% | — |
| Q3 FY25 | $91K | +12% | — |
| Q2 FY25 | $81K | — | — |
Q4 FY26 at a glance
Pure Bioscience, Q4 FY26: revenue $659K (-14% year over year), operating margin -76.3%, net loss $610K, operating cash flow −$414K. The chart follows the revenue to costs, profit and cash.
Questions
What is Pure Bioscience's R&D spending?
Pure Bioscience's R&D spending was $93K in Q4 FY26 (fourth quarter fiscal 2026), +18% from Q3 FY26.
How has Pure Bioscience's R&D spending changed?
Over the last 7 quarters it ranged from $73K (Q4 FY25) to $93K (Q4 FY26).